Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate
A legfontosabb adatok
- Ki végzi
- Inger Lise Gade
- Hol
- Dánia1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 101 fő vett részt
- Kezdés
- 2020. ápr. 17.
- Befejezés
- 2023. dec. 31.
- A vizsgálat típusa
- Megfigyeléses, 6 csoport
- A vizsgált kezelések
- Aspergillus specific proteins in exhaled breath condensate (EBC)
- Pneumocystis jirovecii DNA in exhaled breath condensate (EBC)
- A regiszteradat frissítve
- 2024. február 13.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 6 feltétel megnézéseKevesebb
Ki vehet részt
- Suspected/confirmed PA patients:; Hospitalized or ambulatory patients with a suspected PA at Aalborg University Hospital; Are conscious and able to understand the given study information; Possess legal capacity; Age above 18 years; Informed, signed consent is obtained; Clinically stable, which is defined as patients with stable blood pressure and not in need for other treatments; No need for organ support, which comprises need for vasopressors or inotropes, mechanical ventilation, extra corporal circulation or renal replacement therapy
- Controls; Patients as the PA patients, but where the diagnosis of PA is rejected will be included as controls
- Suspected/confirmed pneumocystis pneumonia patients:; Hospitalized or ambulatory patients with a suspected pneumocystis pneumonia at Aalborg University Hospital - chest x-ray must support the tentative diagnosis of pneumocystis pneumonia; Are conscious and able to understand the given study information; Possess legal capacity; Age above 18 years; Informed, signed consent is obtained; Clinically stable, which is defined as patients with stable blood pressure and not in need for other treatments; No need for organ support, which comprises need for vasopressors or inotropes, mechanical ventilation, extra corporal circulation or renal replacement therapy
- Controls; Patients as the pneumocystis pneumonia patients, but where the diagnosis is rejected
- Healthy controls for the confirmed PA patients and confirmed pneumocystis pneumonia patients In addition, 19 healthy controls (i.e. patients/subjects who undergo diagnostic work-up for benign or indolent hematological diseases without suspected PA or pneumocystis pneumonia) will be recruited, as described below; Healthy controls and patients who are going through diagnostic work-up for indolent hematological cancer types or benign hematological diseases, at the Department of Hematology, Aalborg University Hospital; Same gender and age (within a 10-year range) as an included patient with proven/probable/possible PA (15 subjects); Same gender and age (within a 10-year range) as an included patient with verified pneumocystis pneumonia (4 subjects); Are conscious and able to understand the given study information; Possess legal capacity; Age above 18 years; Informed, signed consent is obtained
Ki nem vehet részt
- PA patients, pneumocystis pneumonia patients and controls:; No upper age limit will be applied
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
In this study, a new, non-invasive method for diagnosis of pulmonary aspergillosis (PA) will be tested in a clinical pilot project.
A vizsgálat 6 csoportja
- PA proven/probable/possible
15 patients with proven, probable or possible PA
Kezelés: Aspergillus specific proteins in exhaled breath condensate (EBC)
- PA suspected, not confirmed
15 patients as the PA patients, but where the diagnosis of PA is rejected.
Kezelés: Aspergillus specific proteins in exhaled breath condensate (EBC)
- Healthy controls (PA)
15 subjects of same gender and age as an included patient with proven/probable/possible PA as healthy controls.
Kezelés: Aspergillus specific proteins in exhaled breath condensate (EBC)
- Pneumocystis pneumonia positive
Four patients with confirmed pneumocystis pneumonia
Kezelés: Pneumocystis jirovecii DNA in exhaled breath condensate (EBC)
- Pneumocystis pneumonia negative
If the diagnosis of pneumocystis pneumonia is not confirmed in a patient with suspected pneumocystis pneumonia, the patient will be included as negative control. Four such patients will be included as healthy controls.
Kezelés: Pneumocystis jirovecii DNA in exhaled breath condensate (EBC)
- Healthy controls (pneumocystis pneumonia)
Four subjects of same gender and age as an included patient with verified pneumocystis pneumonia as healthy controls.
Kezelés: Pneumocystis jirovecii DNA in exhaled breath condensate (EBC)
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2024. február 13.